Breathe Well Live Well
|
Investors appear to wake up to potential of BioTime's Asthma iPhone app (BTX)
Seeking Alpha (registration) Thinly-traded small cap BioTime (BTX +16.1%) jumps on a 4x surge in volume in (what appears to be) belated response to the March 9 announcement by Mount Sinai's Icahn School of Medicine that it is launching a large-scale research study of asthma using … |
View full post on asthma – Google News
|
Asthma treatment passes trial
Investor’s Business Daily Regeneron Pharmaceuticals (NASDAQ:REGN) and Sanofi (NYSE:SNY) jointly announced positive results from a phase 2 study of dupilumab in patients with moderate to severe uncontrolled asthma, who often struggle with daily symptoms and recurring … |
View full post on asthma – Google News
KQED (blog) |
Fresno Pilots Asthma Program Aimed at Tapping Investors for Funds
KQED (blog) Mondragon and all four of her children have asthma -– a disease that has sent them to the hospital more times than she can count. So she is more than willing to open her home to Nunu Sixay, an asthma prevention worker trying to figure out what is … |
View full post on asthma – Google News
|
Angel investors back asthma meds dispenser
Mail Tribune JACKSONVILLE — Lessons learned from a Central Oregon angel investor conference last fall paid off to the tune of $220,000 Thursday for a Bend firm that has developed a dispenser to administer medicine for children with asthma. JettStream walked off … |
View full post on asthma – Google News
 Proactive Investors Australia |
Invion starts second phase trial for asthma treatment
Proactive Investors Australia Invion (ASX: IVX) has initiated the phase II “NIMA” clinical trial to investigate the use of INV102 in patients with mild asthma. The trail, which is funded by the U.S. National Institute of Allergy and Infectious Diseases through a cooperative … |
View full post on asthma – Google News
|
iSonea continues marketing rollout highlighting its asthma management technologies
Proactive Investors USA & Canada “This site is designed to create brand recognition and to ensure iSonea is the 'go to' company for asthma news and innovations. “It does not replace our existing corporate information website, www.iSoneaMed.com, but rather is a consumer adjunct to the … |
View full post on asthma – Google News
 Proactive Investors Australia |
iSonea continues marketing rollout highlighting its asthma management technologies
Proactive Investors Australia “This site is designed to create brand recognition and to ensure iSonea is the 'go to' company for asthma news and innovations. “It does not replace our existing corporate information website, www.iSoneaMed.com, but rather is a consumer adjunct to the … |
View full post on asthma – Google News
 Proactive Investors Australia |
iSonea expands board expertise with new director appointments
Proactive Investors USA & Canada iSonea recently reached an important milestone with the start of its first large US post-market study of its WheezoMeter™ monitoring device in paediatric patients with a range of asthma symptom severity. The study will include patients who are too … iSonea Announces Changes to Board of Directors |
View full post on asthma – Google News
Proactive Investors Australia |
iSonea expands board expertise with new director appointments
Proactive Investors Australia iSonea recently reached an important milestone with the start of its first large US post-market study of its WheezoMeter™ monitoring device in paediatric patients with a range of asthma symptom severity. The study will include patients who are too … iSonea debuts asthma app platform |
View full post on asthma – Google News
 mobihealthnews |
iSonea reaches milestone with launch of U.S. paediatric asthma study
Proactive Investors USA & Canada iSonea (ASX: ISN, OTCQX: ISOAY) has begun its first large US post-market study of its WheezoMeter™ monitoring device in paediatric patients with a range of asthma symptom severity. The study will include patients who are too young to be tested with … iSonea Announces Initiation of Pediatric Asthma Study iSonea begins recruiting for pediatric asthma trial iSonea to Build Mobile Asthma Management Apps on Qualcomm's Platform |
View full post on asthma – Google News